Intravitreal steroids may reduce progression of diabetic retinopathy

MedPage Today (12/14, Walsh) reported that, according to a study published in the Dec. issue of the Archives of Ophthalmology, “intravitreal triamcinolone acetonide reduced progression of diabetic retinopathy more than laser photocoagulation.” After analyzing “data from a randomized trial” including “840 eyes in 693 patients,” Johns Hopkins University researchers found that “the cumulative probability of progression from nonproliferative to proliferative diabetic retinopathy at two years was” 31% for photocoagulation, 29% for “1 mg triamcinolone…P=0.64 compared with the laser group,” and 21% for “4 mg triamcinolone…P=0.005 compared with the laser group.” Nevertheless, the authors cautioned that “corticosteroids cannot be recommended at this time,” because “the treatment carries risks of cataracts and glaucoma.”   More information on eye and vision care issues visit


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: